Medicare Enrolled

Dr. Arvinder Gill, D.O.

Pain Medicine · Palmdale, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
819 AUTO CENTER DR, Palmdale, CA 93551
7602410350
In practice since 2011 (14 years)
NPI: 1528351582 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gill

Dr. Arvinder Gill is a pain medicine specialist in Palmdale, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Gill performed 1,258 Medicare services across 852 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gill received a total of $1,054 from 14 pharmaceutical and/or device companies across 81 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 14 years in practice ▲ Top 37% volume in CA $1,054 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,258
Medicare services
Top 37% in CA for pain medicine
852
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
456 $103 $400
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
325 $69 $350
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
100 $61 $500
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
82 $153 $1,000
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
56 $81 $500
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
53 $195 $1,000
Psychological test evaluation, first hour
A healthcare professional evaluates the results of psychological testing during an initial one-hour session.
52 $96 $779
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
39 $109 $1,000
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
24 $58 $1,000
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
17 $80 $4,000
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
15 $123 $5,467
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
15 $1 $7
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
12 $234 $6,000
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
12 $71 $3,000
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,054
Total received (2018-2024)
Avg $151/year across 7 years
Bottom 45% in CA for pain medicine
14
Companies
81
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,054 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$59
2023
$61
2022
$210
2021
$31
2020
$12
2019
$368
2018
$314

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Curonix LLC
$23
Medtronic, Inc.
$18
Forte Bio-Pharma LLC
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$290
Boston Scientific Corporation
$271
Abbott Laboratories
$144
Collegium Pharmaceutical, Inc.
$85
Medtronic, Inc.
$49
Pernix Therapeutics Holdings, Inc.
$31
Nevro Corp.
$30
Scilex Pharmaceuticals Inc.
$24
Daiichi Sankyo Inc.
$24
FIDIA PHARMA USA INC.
$23
Curonix LLC
$23
DePuy Synthes Sales Inc.
$21
Medtronic USA, Inc.
$20
Forte Bio-Pharma LLC
$18
Top 3 companies account for 66.9% of all-time payments
Associated products mentioned in payments ›
Belbuca · CHANTIX · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · General - Pain Management · Hymovis · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · LYRICA · Morphabond ER · NALOCET · ORTHOVISC · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · Senza Spinal Cord Stimulation System · WaveWriter Alpha Prime 16 · XTAMPZA · ZOHYDRO ER · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Palmdale?
Compare pain medicines in the Palmdale area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
10
Per 100K population
0.1
County median income
$87,760
Nearest hospital
ANTELOPE VALLEY HOSPITAL
9.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gill is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gill experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gill performed 456 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $1,054 from 14 companies across 81 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other pain medicines in Palmdale?
Dr. Gill's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →